FilingSEC EDGAR6-K
XORTX Therapeutics Initiates Manufacturing of Gout Treatment Candidate
· SEC accepted
StageClinical Preparation
Filing content
The company has commenced production of GMP drug substance and tablets for its XORLO gout treatment candidate to support clinical trials and future FDA marketing approval.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…